Latest Medical Research stories in Health, with AI-generated summaries from NewsSnap.ai.
Start a 30-day free trial to follow this topic and get personalized updates.
Follow Medical ResearchResearchers have identified specific genes associated with Obsessive-Compulsive Disorder (OCD). This discovery is significant as it could pave the way for the development of new therapeutic approaches and more targeted treatments for individuals living with the condition.
A recent study indicates that prolonged fatigue experienced by breast cancer patients may stem primarily from stress and depression, rather than direct cardiac damage. This finding is significant as it could inform more targeted therapeutic approaches to manage this debilitating side effect, potentially improving patient quality of life.
New research indicates that severe asthma continues to be active in most patients, despite the widespread application of biologic treatments. This finding underscores the ongoing challenges in managing severe asthma and suggests a critical need for further therapeutic advancements to improve patient outcomes.
A US randomized controlled trial published in The Lancet Infectious Diseases indicates that an extended Paxlovid regimen, up to 25 days, did not alleviate cognitive issues, autonomic symptoms, or exercise intolerance in adults with long COVID. This research provides crucial insights into long COVID and viral persistence, suggesting that longer Paxlovid courses may not be an effective treatment for these persistent symptoms.
Scientists at Scripps Research have created ECG-CLIP, an innovative AI model that significantly improves the detection and prediction of various heart diseases. Published in Lancet Digital Health, this tool was trained on over 1.7 million electrocardiograms and clinical notes, making it highly adaptable for diverse clinical tasks, especially in data-limited settings.
A Danish analysis presented at ESC Congress 2026 and published in Lancet Regional Health – Europe indicates that initiating statin therapy early after a type 2 diabetes diagnosis is associated with a greater reduction in dementia risk. Patients who started statins within one year of diagnosis showed a 15% lower relative risk of dementia after 10 years compared to those who waited five years or more. This research highlights the potential importance of timely statin intervention for improving cognitive outcomes in individuals with type 2 diabetes.